Clinical Trial Update: CIK in Treating Patients With Bladder Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of cytokine-induced killer (CIK) cell therapy for bladder cancer, with the study listed as active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CIK Cells

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Urinary Bladder Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING